nach oben

Die Gynäkologie

Erschienen in:

01.04.2005 | Zum Thema

Hormondiagnostik mit Chemilumineszenz

verfasst von: PD Dr. S. Albrecht, T. Zimmermann, W. Distler

Erschienen in: Die Gynäkologie | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Zusammenfassung

Chemilumineszenzmethoden sind heutzutage aus den modernen labormedizinischen, biochemischen und molekularbiologischen Laboratorien nicht mehr wegzudenken. Ein Hauptanwendungsgebiet stellt die immunologische Hormondiagnostik dar, insbesondere in niedrigen Konzentrationsbereichen. Die hochentwickelte und sehr empfindliche Photonenmesstechnik kommt der Entwicklung extrem sensibler Immunoassays zu Gute. Ausgehend von einigen Grundlagen der Chemilumineszenz werden insbesondere moderne Applikationen auf dem Gebiet der Immunoassays bis hin zur Entwicklung vollautomatischer Gerätesysteme besprochen. Die Umweltfreundlichkeit und große Anwendungsbreite dieser Technologie favorisiert sie für zukünftige Entwicklungen.

Albrecht S, Brandl H, Adam W (1990) Chemilumineszenz-Reaktionen. Chem Unserer Zeit 24: 227–238

Hercules DM (1969) The mechanism of chemiluminescence. Acc Chem Res 80: 301–309

Chandross EA, Sonntag FJ (1964) Chemiluminescence reactions. J Am Chem Soc 86: 3179–3183

Rauhut MM, Sheenan D, Clarke RA, Semsel AM (1965) Structural criteria for chemiluminscence in acylperoxide decomposition reactions. Photochem Photobiol 4: 1097–1110

Stanley PE (1992) Luminometers for chemiluminescence measurements. J Biolumin Chemilumin 7: 157–168

Campbell AK (1988) Chemiluminescence. VCH, Weinheim

Albrecht S, Beckert R, Böhm WD (1989) Zur Anwendung der Peroxyoxalat-CL in der biochemischen Analytik: Bestimmung von Oxalat. J Clin Chem Clin Biochem 27: 451–454

Albrecht S, Hornack H, Freidt T, Böhm WD, Weis K, Reinschke A (1993) Determination of serum oxalate using peroxyoxalate chemiluminescence or free oxalic acid. J Biolumin Chemilumin 8: 21–24

Albrecht S, Brandl H, Schönfels C (1994) Oxalate — only endproduct of metabolism? Angew Chem Int Ed Engl 33: 1780–1781

10.

Albrecht S, Hornak H, Brandl H, Freidt T, Böhm WD, Weis K, Reinschke A (1992) Free oxalic acid chemi-luminescence for the determination of serum oxalate and organo-phosphorous compounds. J Anal Chem 342: 175–176

11.

Albrecht S, Brandl H, Steinke M, Freidt T (1994) Chemiluminescent enzyme immunoassay of PSA based on indoxyl phosphate substrate. Clin Chem 40: 1970–1971

12.

Albrecht S (1993) Zur Anwendung moderner Chemilumineszenzsysteme in der biochemischen Analytik. Habilitationsschrift, TU Dresden

13.

Baret A, Fert V (1989) T₄ and TSH immunoassays using luminescent enhanced xanthine oxidase assay. J Biolumin Chemilumin 4: 149–153

14.

Stanley PE, Kricka LJ (1991) Bioluminescence & chemiluminescence — current status. Wiley, Chichester, pp 187–190, 191–194

15a.

Wood WG (1989) Chemiluminescence immunoassay — dream or reality. J Biolumin Chemilumin 4: 79–86

15b.

Wood WG (1984) Chemiluminescence immunoassay. J Clin Chem Clin Biochem 22: 905–909

15c.

Straßburger CJ, Fricke H, Gadow A, Klingler W, Wood WG (1983) Direkter Chemilumineszenz-Immunoassay. Ärztl Lab 29: 75–81

16.

Schaap AP, Goudar JS, Romano LJ (1991) 4. Internationales Symposium für quantitative Lumineszenz-Spektrometrie in den biomedizinischen Wissenschaften. Gent, Belgien, Abstract-Band S 49

17.

Bayens RG, de Keukeleire D, Korkidis K (1991) In: Luminescence techniques in chemical and biochemical analysis. Marcel Dekker, New York, pp 567–577

18.

Miska W, Geiger R (1991) In: Stanley PE, Kricka LJ (eds) Bioluminescence & chemiluminescence — current status. Wiley, Chichester, pp 183–187

19.

Schaap AP (1996) Chemiluminescent reaction of lumigen^Tm APS with AP. Int Sym BL & CL, Woods Hole

20.

Miska W, Geiger R (1989) New sensitive bioluminescence enhanced detection systems for immunoassays. J Biolum Chemilum 4: 119–127

21.

Hauber R, Miska W, Schleinkofer L, Geiger R (1989) New sensitive radioactive free bioluminescence enhanced detection systems in protein blotting and nucleid acid hybridization. J Biolum Chemilum 4: 367

22.

Kricka LJ, Thorpe GHG (1986) Photograph detection of CL and BL reactions. Meth Enzymol 133: 404–420

23.

Weeks I, Beheshti I, Mc Capra F, Campbell AK, Woodhead JS (1983) Acridinium esters as high specific activity labels in immunoassays. Clin Chem 29: 1474–1479

24.

Law S J, Miller T, Piran U, Klukas C, Chang S, Unger J (1989) Novel substituted aryl acridinium esters and their use in immunoassays. J Biolumin Chemilumin 4: 88–98

25.

Kinkel T, Lubbers H, Schmidt E, Molz P, Skrzipczyk HJ (1989) Synthesis and properties of new luminescent acridinium derivates and their application in immunoassays. J Biolumin Chemilumin 4: 136–139

26.

Mattingly PG (1991) Chemiluminescent 10-Methyl-acridinium-salts. J Biolumin Chemilumin 6: 107–114

27.

Zorner G, Stavenuiter JFC (1989) New acridinium compounds useful as chemiluminogenic labels for both heterogeneous and homogeneous immunoassays. Eur.-Patent Appl. 324.202

28.

Mattingly G, Bennett LG (1988) Chemiluminescent acridinium and phenanthridinium salts. Eur.-Patent Appl. 273.115

29.

Patel A, Cormier MC (1984) Calcium-sensitive photoproteins as bioluminescent labels in immunoassay. In: Kricka LJ, Stanley PE, Thorpe GHG, Whitehead TP (eds) Analytical applications of bioluminescence and chemiluminescence. Academic Press, London, pp 273–283

30.

Stults NL, Stocks NA, Cummings RD, Cormier MJ, Smith DF (1991) Applications of recombinant bioluminescent proteins as probes for proteins and nucleic acids. In: Stanley PE, Kricka LJ (eds) Bioluminescence and chemiluminescence: current status. Wiley, Chichester, pp 533–537

31.

Bronstein I, Edwards B, Voyta JC (1990) 1,2-Dioxetanes, novel chemiluminescent enzyme substrates. J Biolumin Chemilumin 5: 99–111

32.

Bronstein I, Voyta JC, Lazzari KG, Murphy OJ, Edwards B, Kricka LJ (1990) Improved chemiluminescent detection of AP. Biotechnique 9: 160–161

33.

Schaap AP, Sandison MD, Handley RS (1987) Chemical and enzymatic triggering of 1,2 dioxetanes. Tetrahedron Lett 28: 1159–1162

34.

Bronstein I (1990) Method of detecting a substance using enzymatically-induced decomposition of dioxetanes. US-Patent 4.978.614

35.

Schaap AP, Akhaven H, Romano LJ (1989) CL substrates of AP-applications to ultrasensitive enzyme linked immunoassaya and DNA probes. Clin Chem 35: 1863–1864

36.

Bronstein I, Juo RR, Voyta JC, Edwards B (1991) Novel chemiluminescent adamantyl 1,2-dioxetane enzyme substrates. In: Stanley PE, Kricka LJ (eds) Bioluminescence and chemiluminescence: current status. Wiley, Chichester, pp 73

37.

Kricka LJ, Schmerfeld-Pruss D, Edwards B (1991) CL assays using proenhancers and antiproenhancers. J Biolumin Chemilumin 6: 231–238

38.

Bronstein I, Voyta JC, Thorpe GHG, Kricka LJ, Armstrong G (1989) CL assay of AP applied in a ultrasensitive enzyme immunoassay of thyrotropin. Clin Chem 35: 1441–1446

39.

Kricka LJ (1989) Luminescent immunoassay. J Fed Clin Chem 1: 24–27

40.

Kricka LJ, Thorpe GHG (1985) Recent progress in bioluminescence and chemiluminescence. Ann Biol Clin 43: 457–462

41.

Nishizono I, Ashihara Y, Suzuki N et al. (1990) Chemiluminescent enzyme immunoassay for tumormarkers using AM PPD. Clin Chem 36: 1097–1101

42.

Thorpe GHG, Bronstein I, Kricka LJ, Edwards B, Voyta JC (1989) Specific protein binding reactions monitored with ligand ATP conjugated and firefly luciferase. Clin Chem 35: 95–110

43.

Carrico RC, Yeung KK, Schroeder HR, Boguslaski RC, Buckler RT, Christener JE (1976) Specific protein binding reactions monitored with ligand-ATP-conjugates and firefly luciferase. Anal Biochem 76: 95–110

44.

Takayasu S, Maeda M, Tsuji A (1984) CL enzyme immunoassay using beta-D-galactosidase as label and the TCPO-fluorescent dye system. J Immunol Meth 33: 317–25

45.

Kojo S, Tokumaru S, Kishida E (1992) Peroxyoxalate chemiluminescent assay in aqueous solution with γ-cyclodextrin. Clin Chem 38: 788–791

46.

Wannlund J, Azari J, Levine L, DeLuca M (1980) A bioluminescent immunoassay for methotrexate at the subpicomole level. Biochem Biophys Res Commun 96: 440–446

47.

Der-Ballen GP, Jaeger F, Guilford FT (1985) Labelling system for specific binding assays. Eur.-Patent Appl. 141.581

48.

Shapiro R, Chan J, Pierson A, Vaccaro K, Quick J (1984) Protein enhanced fluorescein CL used in an immunoassay for rubella antibody in serum. Clin Chem 30: 889–893

49.

Albrecht S, Brandl H, Böhm WD, Beckert R, Kittle E, Menschikowski M, JaroO W (1990) Application of peroxyoxalate chemiluminescence in analytical biochemistry. J Anal Chem 337: 93–94

50.

Arakawa H, Maeda M, Tsuji A (1982) CL enzyme immunoassay of 17-a-hydroxyprogesterone. Chem Pharm Bull 30: 3039–3042

51.

Bronstein I, Kricka LJ (1989) Clinical applications of luminescent assays for enzymes and enzyme labels. J Clin Lab Anal 3: 316–321

52.

Terouanne B, Carrie ML, Nicolas JC, Crastes de Paulet A (1986) Bioluminescent immunosorbent for rapid immunoassays. Anal Biochem 154: 118–125

53.

Carrie ML, Terouanne B, Brochu M, Nicolas JC, Crastes do Paulet A (1986) Bioluminescent immunoassay of progesterone. Anal Biochem 154: 126–131

54.

lkariyama Y, Suzuki S, Aizawa M (1983) Luminescence catalyst immunoassay 0-2-microglobuline. Enzyme Microb Technol 5: 215–219

55.

Thorpe GHG, Kricka LJ (1989) Incorporation of enhanced CL reactions into fully automated enzyme immunoassays. J Biolumin Chemilumin 3: 97–100

56.

Urdea MS, Warner BD (1990) Chemiluminescent doubletriggered 1,2-dioxetanes. Eur.-Patent Appl. 401.001

57.

Tafti HA, DeSilva R, Arghavani Z, Eickholt RA, Handley RS, Schaap AP (1994) In: Bioluminescence & chemiluminescence — fundamentals and applied aspects. Wiley, Chichester, pp 199–203

58.

Collins WB, Barnard GJ, Kim JB et al. (1983) Chemiluminescenoe immunoassays for plasma steroids and urinary steroid metabolites. In: Hunter WM, Corrie JET (eds) Immunoassay for clinical chemistry. Churchill Livingstone, Edinburgh, pp 373–397

59.

Schroeder HR, Boguslaski RC, Carrico RJ, Buckler RT (1978) Monitoring specific binding reactions with chemiluminescence. Methods Enzymol 57: 424–445

60.

Buckler RT, Schroeder HR (1980) Chemiluminescent naphthalene-1,2-dicarboxylic acid hydrazide-labeled polypeptides and proteins. US-Patent 4.225.485

61.

Baldwin TO, Holzman TF, Holtzman RB (1986) Active center based immunoassay approach using bacterial luciferase. Meth Enzymol 133: 248–264

62.

Jablonski E (1985) The preparation of bacterial luciferase conjugates for immunoassays. Anal Biochem 148: 199–206

63.

Schroeder HR, Carrico RJ, Boguslaski RC, Christener JE (1976) Specific binding reactions monitored with ligand cofactor conjugates and bacterial luciferase. Anal Biochem 722: 83–92

64.

Baret A, Fort V, Aumaille J (1990) Application of long term enhanced xanthin oxidase-induced luminescence in solid phase immunoassays. Anal Biochem 187: 20–26

65.

Gillespie P, Hudspeth A (1991) Chemiluminescent blotting. J Cell Biol 122: 4–11

66.

Jain V, Magrath I (1991) Blotting based on chemiluminescence. Anal Biochem 199: 119–126

67.

Sedgwick S, Ho C, Woodgate R (1991) Bacterial chemiluminescence blotting. J Bacteriology 173: 5604–5611

68.

Woodgate R, Ennis D (1991) DNA blotting by chemiluminescence. Moll Gen Genet 229: 10–16

69.

Arnold LA, Hammond PW, Wiese WA, Nelson NC (1989) Assay formats involving acridinium ester DNA probes. Clin Chem 35: 1588–1594

70.

Pollard-Knight DV (1991) Rapid and sensitive luminescent detection methods for nucleic acid detection. In: Stanley PE, Kricka LJ (eds) Bioluminescence and chemiluminence: current status. Wiley, Chichester, pp 83–90

71.

Beck S, Koster H (1990) Applications of dioxetan probes to molecular biology. Anal Chem 62: 2258–2270

72.

Balaguer P, Terouanne B, Boussioux AM, Nicolas JC (1989) Use of bioluminescence in nucleid acid hybridization reactions. J Biolumin Chemilumin 4: 302–309

73.

Hauber R, Miska W, Schleinkofer L, Geiger R (1989) New, sensitive, radioactive-free bioluminescence enhanced detection system in protein blotting and nucleic acid hybridization. J Biolumin Chemilumin 4: 367–372

74.

Balaguer P, Bonafe N, Terouanne B, Boussioux AM, Baret A, Nicolas JC (1991) Luminescent detection of DNA probes: a comparative study of four luminescent detection systems. In: Stanley PE, Kricka LJ (eds) Bioluminescence and chemiluminence: current status. Wiley, Chichester, pp 187–190

75.

Albrecht S, Brandl H, Schönfels C, Adam W (1992) Biolumineszenz. Chem Unserer Zeit 26: 63–69

76.

Steiner C (1992) Luminescent molecular biology. Biotech Forum Eur 3: 123–127

77.

Hercules DM, Lytle FE (1966) Chemiluminescence of Ruthenium compounds. J Am Chem Soc 88: 4745–4747

78.

Knight AW, Greenway GM (1994) Electrochemiluminescence of Ruthenium organyl compounds. Analyst 119: 879–886

79.

Lauschke H (1994) Untersuchungen von reaktiven Sauerstoffspezies bei Patienten mit kolorektalen Karzinomen unter besonderer Berücksichtigung der Spurenelemente Cu, Zn und Se. Dissertation, TU Dresden

80.

Allen RC, Stjernholm RC, Steck RH (1972) Cellular chemiluminescence. Biochem Biophys Res Comm 47: 679–687

81.

Albrecht S, Zimmermann T, Weis K, Trausch M (1994) Chemiluminometric measurement of plasma and intracellular oxalate concentration in patients with acute or chronic inflammatory diseases. In: Campbell AK, Kricka LJ, Stanley P (eds) Bioluminescence and chemiluminescence. Fundamentals and applied aspects. Wiley, Chichester, pp 253–257

82.

Albrecht S, Zimmermann T (1993) Chemiluminometric detection of oxidatively modified LDL. In: Szalay A, Kricka LJ, Stanley P (eds) Bioluminescence and chemiluminescence. Status Report. Wiley, Chichester, pp 503–507

83.

Zimmermann T, Albrecht S (1993) Chemiluminometric detection of lipidperoxidation state in patients with gastrointestinale cancer. In: Szalay A, Kricka LJ, Stanley P (eds) Bioluminescence and chemiluminescence. Status Report. Wiley, Chichester, pp 496–9

84.

Albrecht S, Lattke P, Kostka H, Neumeister V, Trausch M, Jaroß W (1994) HDL inhibits the peroxydation of LDL. Klin Lab 40: 933–935

85.

Hunter EM, Sutherland LA, Cree IA et al. (1993) Chemiluminescent tumor sensitivity assay. Eur J Surg Oncol 19: 242–246

86.

Christensen MJ, Pussey NW (1994) Cellular luminescence. Biochim Biophys Acta 1225: 338–347

87.

Bierhaus A, Nawroth PP (1993) Chemiluminescent assays. Serva Quart News 1: 11–14

88.

Bierhaus A, Hemmer CJ, Mackman N, Kutob R, Ziegler R, Dietrich M, Nawroth PP (1995) Antiparasitic treatment of patients with P. falciparum malaria reduced the ability of patient serum to induced tissue factor by decreasing NFκB activation. Thromb Haemost 73: 3039–3048

89.

Zimmermann T, Albrecht S, Nagel M, Trausch M, Benusch T (1993) Measurement of ATP, peroxidation state and CL response in cases of aortic surgery. In: Campbell AK, Kricka LJ, Stanley P (eds) Bioluminescence and chemiluminescence. Fundamentals and applied aspects. Wiley, Chichester, pp 470–473

90.

Collowick SP (1986) Methods in enzymology, vol. 133. Bioluminescence and chemiluminescence. Academic Press

91.

van Dyke K (1987) Cellular chemiluminescence. CRC Press

92.

Wondrak G, Pier T, Tressl R (1995) Light from Maillard reaction. J Biolumin Chemilumin 10: 277–284

93.

Adam W, Ahrweiler M, Vlcek P (1995) Chemiluminescence of labile 1,2 dioxetanes and epoxicles. J Am Chem Soc 117: 9690–9692

94.

Santer M, Adam W (1995) Oxyfunctionalization of benzofurans by singlet oxygen. Acc Chem Res 28: 289–298

95.

Khan AU, Wilson T (1995) Chemiluminescence and reactive O₂-species. Chem Biol 2: 437–445

96.

Adam W, Cilento G (1982) In chemical and biological generation of excited states. Academic Press, New York, pp 277

97.

Phillip MJ, Maximuke PP (1989) Application of peroxyoxalate CL in tumor therapy. Oncology 46: 266–272

98.

Albrecht A, Brandl H, KöstIer E (1989) Ein neuer Suchtest zur Porphyriediagnostik. Z Klin Med 44: 2071–2073

99.

Albrecht S, Zimmermann T, Beutner M, Distler W (1995) Chemiluminometric measurement of plasma and intracellular oxalate. Eur J Clin Chem Clin Biochem 33: A32

100.

Albrecht S, Brandl H, Steinke M, Freidt T (1994) Chemiluminescent enzyme immunoassay of PSA based on indoxyl phosphate substrate. Clin Chem 40: 1970–1971

101.

Albrecht S, Brandl H, Schönfels C (1994) Oxalat — tatsächlich nur ein humanes Stoffwechsel-Endprodukt? Angew Chem 106: 1864–1865

102.

Brandl H, Albrecht S (1994) Nachweis okkulter Blutspuren in der Forensischen und Klinischen Chemie. MNU 47: 226–233

103.

Albrecht S, Lattke P, Koska H, Neumeister V, Trausch M, Jaroß W (1994) HDL inhibits the formation of primary modified LDL generated by photooxygeneration. Klin Lab 40: 933–935

104.

Albrecht S, Zimmermann T, Weis K (1994) Chemiluminometric measurement of plasma and intracellular oxalate concentrations in patients with acute or chronic inflammatory diseases. In: Campbell AK, Kricka LJ, Stanley P (eds) Bioluminescence and chemiluminescence. Fundamentals and applied aspects. Wiley, Chichester, pp 253–256

105.

Zimmermann T, Albrecht S (1994) Measurements of ATP in blood plasma samples in cases of aortic surgers. In: Campbell AK, Kricka LJ, Stanley P (eds) Bioluminescence and chemiluminescence. Fundamentals and applied aspects. Wiley, Chichester, pp 470–473

106.

Knorr A, Dörfler A, Albrecht S, Herrmann T, Kumpf R, Voigtmann L, Geyer P (1994) Verlaufskontrolle der radiogen induzierten Lungenfibrose durch Serum-PIIIP-Bestimmungen am Tiermodell des Minischweines. Lab Med 18: 405

107.

Albrecht S, Zimmermann T (1994) Chemiluminometric measurement of plasma and intracellular oxalate concentration in patients with acute inflammatory diseases. Lab Med 18: 379

108.

Zimmermann T, Albrecht S (1995) Die Rolle reaktiver O₂-Metaboliten in der Pathogenese gastrointestinaler Tumoren – eine Verlaufsstudie. Med Klin 90: 15–18

109.

Albrecht S, Zimmermann T, Beutner M, Distler W (1995) Chemiluminometric measurement of plasma and intracellular oxalate concentrations in pediatric and adult septic patients. Eur J Clin Chem Clin Biochem 33: A32

110.

Zimmermann T, Albrecht S, Ockert D et al. (1995) Monitoring of PTH during surgery of parathyroid glandules using a modified and rapid chemiluminescence immunoassay. Eur J Clin Chem Clin Biochem 33: A32

111.

Albrecht S (1995) Körpereigenes Oxalat. Naturw Rdsch 48: 315–316

112.

Albrecht S (1995) Zum Einfluß toxischer Spurenelemente bei der in vitro-Fertilisationsbehandlung. Gesundh Reg: 1: 18

113.

Albrecht S (1995) Isotopische und nichtisotopische Reportergenassays. Workshop der Fa. Berthold, Dresden. Abstractband S 23

114.

Albrecht S (1995) Moderne Trends angewandter Chemi- und Biolumineszenz. Nachr Chem Techn Lab 43: 621

117.

Albrecht S, Brandl H, Zimmermann T (1996) Chemilumineszenz — Reaktionssysteme und ihre Anwendung unter besonderer Berücksichtigung von Biochemie und Medizin. Hüthig, Heidelberg

118.

Göhler T, Hanefeld M, Albrecht S (1996) Bedeutung des neuen Risikofaktors Insulin-Like Growth Factor-I für die Mikro- und Makroangiopathie und für die periphere Neuropathie bei Diabetes mellitus Typ II. In: Hanefeld M, Leonhardt W (Hrsg) Das Metabolische Syndrom: ein integriertes Konzept zur Diagnostik und Therapie eines Clusters von Zivilisationskrankheiten. Fischer, Jena, S 182–184

119.

Nagel M, Zimmermann T, Ockert D, Albrecht S, Saeger HD (1996) Perioperatives Parathormon-Monitoring mittels eines modifizierten Chemilumineszenz-Immunoassays. Langenbecks Arch Chir [Suppl II]: 1272–1273

120.

Albrecht S, Zimmermann T, Flachowsky S, Beutner M, Distler W (1996) New chemiluminometric measurement of plasma NO, endothelin and renin in pregnancy. 2nd International Conference on Biochemicstry & Molecularbiology of NO, Los Angeles, Abstracts p 124

121.

Albrecht S, Zimmermann T, Saeger HD, Distler W (1996) Chemiluminometric detection of NO-, Oxalate and Endothelin in patients with S.I.R.S. 7th International Symposium on Luminescence and Spectrometry, Nizza. Abstracts p 42

122.

Zimmermann T, Albrecht S, Lauschke H, Ludwig K (1995) Reaktive Sauerstoffspezies in der Pathogenese gastrointestinaler Tumoren — eine Verlaufsstudie. Med Klin 90 [Suppl 1]: 15–18

123.

Albrecht S, Zimmermann T, Saeger HD, Distler W (1996) Chemiluminometric measurement and interaction of endothelin, oxalate and NO in patient with systemic inflammatory response syndrome. J Biolumin Chemilumin 11: 240

124.

Brandl H, Albrecht S, Zimmermann T (1996) Fascinating CL demonstrations. 9th International Symposium on bioluminescence and chemiluminescence, Woods Hole

125.

Zimmermann T, Albrecht S, Bierhaus A, Brandl H, Distler W (1996) Luminometric detection of NF-κB and procalcitonin as central mediators of sepsis. J Biolumin Chemilumin 11: 240

126.

Zimmermann T, Albrecht S, Nagel M, Bauer R, Menschikowski M, Saeger HD (1996) Low T3 syndrome in septic patients — phenomenon or important pathogenetic factor? Exp Clin Endocrinol Diab 104 [Suppl 1]: 90

127.

Zimmermann T, Albrecht T, Bierhaus A, Distler W, Saeger HD (1996) Low T3 syndrome in septic patients — phenomenon or important pathogenetic factor. J Hung Surg Soc 49 [Suppl]: 139

128.

Zimmermann T, Albrecht S, Bierhaus A, Distler W, Saeger HD (1996) NFkB — a central mediator of sepsis? J Hung Surg Soc 49 [Suppl]: 139

129.

Albrecht S, Zimmermann T, Freidt M, Saeger HD, Distler W (1997) Interaction of NO,endothelin and oxalate in patients with systemic inflammatory response syndrome (S.I.R.S.). In: Stanley PE, Kricka LJ, Hastings JW (eds) Bioluminescence and chemiluminescence: Molecular reporting with photons. Wiley, Chichester New York, pp 327–329

130.

Brandl H, Albrecht S, Zimmermann T (1997) New fascinating demonstrations with chemiluminescence. In: Stanley PE, Kricka LJ, Hastings JW (eds) Bioluminescence and chemiluminescence: Molecular reporting with photons. Wiley, Chichester New York, pp 196–198

131.

Zimmermann T, Albrecht S, Bierhaus A et al. (1997) NFκB — a new mediator of sepsis. In: Stanley PE, Kricka LJ, Hastings JW (eds) Bioluminescence and chemiluminescence: Molecular reporting with photons. Wiley, Chichester New York, pp 330–333

132.

Albrecht S, Zimmermann T, Brandl H, Saeger HD, Distler W (1997) Chemilumineszenz am Rande der Jahrtausendwende — von der Jahrmarktskuriosität zum unentbehrlichen Werkzeug der Laboratoriumsdiagnostik. J Lab Med 21: 191–204

133.

Albrecht S, Zimmermann T, Freidt M, Freidt T, Saeger HD, Distler W (1997) Interaction of NO, endothelin und oxalate in patients with systemic inflammatory response syndrome (S.I.R.S.). Biomed Chromatogr 11: 77–78

134.

Albrecht S, Zimmermann T, Ockert D, Oehlschläger S, Heinzmann J, Schilling JU (1997) Verhindert Selen die Peroxynitritbildung aus NO bei gefäßchirurgischen Eingriffen? Med Klin 92 [Suppl III]: 10–11

135.

Börner J, Zimmermann T, Albrecht S, Roesner D (1997) Selensubstitution bei schweren entzündlichen chirurgischen Krankheitsbildern sowie Verbrennungen und Verbrühungen im Kindesalter. Med Klin 92 [Suppl III]: 17–19

136.

Zimmermann T, Albrecht S, Kühne H, Vogelsang U, Grützmann R, Kopprasch S (1997) Selensubstitution bei Sepsispatienten — Eine prospektiv randomisierte Studie. Med Klin 92 [Suppl III]: 3–4

137.

Zimmermann T, Bierhaus A, Nagel M, Albrecht S, Saeger HD (1997) NFκB-Aktivierung — ein zentraler Mediator der Sepsis. Langenbecks Arch Chir [Suppl I]: 363–367

138.

Albrecht S (1997) Fertilitätsdiagnostik in der Frauenheilkunde, ein Erfahrungsbericht mit AxSYM. ABBOTT Forum Labordiagnostik, Burg

139.

Albrecht S, Beutner M, Zimmermann T, Distler W (1997) DHEA-S inhibits the peroxidation of lipoproteins by singulet oxygen. Exp Clin Endocrinol Diabetes 105 [Suppl I]: 66

140.

Albrecht S, Zimmermann T, Beutner M, Hanke S, Distler W (1997) A new chemiluminometric method for fast and specific determination of total estrogen in human urine. Eur J Clin Chem Clin Biochem 35: A99

141.

Albrecht S, Zimmermann T, Beutner M, Pietzsch J, Distler W (1997) DHEA-S inhibits the generation of hydroperoxy groups in lipoproteins. Eur J Clin Chem Clin Biochem 35: A99

142.

Albrecht S, Zimmermann T, Brandl H (1997) Chemiluminescence at the turn of the millennium — from annual fair curiosity to indispensable tool of laboratory diagnostics. Eur J Clin Chem Clin Biochem 35: A75

143.

Albrecht S, Zimmermann T, Ockert D, Oehlschläger S, Heinzmann J, Schilling JU (1997) Selenium inhibits the generation of peroxynitrite during vascular surgery — a clinical study. Eur J Clin Chem Clin Biochem 35: A100

144.

Albrecht S, Zimmermann T, Pilarsky C, Oehlschläger S, Dittert DD, Brandl H (1997) Chemiluminometric determination of oxalate in several body fluids and tissue samples. Eur J Clin Chem Clin Biochem 35: A75

145.

Blümlein K, Blasum C, Wozel G, Albrecht S (1997) Effects of dapsone metabolites on chemiluminescence response of whole blood. Eur J Clin Chem Biochem 35: A78

146.

Brandl H, Haufe M, Albrecht S (1997) Chemiluminescence — a historical review with fascinating demonstration experiments. Eur J Clin Chem Clin Biochem 35: A78

147.

Deutschmann K, Richter B, Albrecht S, Zimmermann T, Hanke S, Distler W (1997) Chemiluminometric determination of CA 125 and verious cytokines in cases of ovarian carcinoma. Eur J Clin Chem Clin Biochem 35: A104

148.

Eberlein T, Albrecht S, Pinzer T, Zimmermann T, Schackert G (1997) Somatotropin-monitoring by using a rapid modified chemiluminescence immunoassay in cases of growth hormone producing pituitary adenomas. Eur J Clin Chem Clin Biochem 35: A79

149.

Findeisen R, Albrecht S, Distler W (1997) Chemiluminescence immunoassay of tissue polypeptide antigen (TPA) in cases of breast cancer. Eur J Clin Chem Clin Biochem 35: A105

150.

Freidt A, Albrecht S, Richter B, Distler W (1997) Clinical validity of chemiluminometric determinations of tumor markers, cytokine receptors and adhesion molecules in diagnosis and treatment of ovarian carcinomas. Eur J Clin Chem Clin Biochem 35: A105

151.

Hanefeld M, Göhler T, Albrecht S (1997) Epidemiologische Studie zur Bedeutung von Insulin-Like-Growth Faktor 1 für Spätkomplikationen bei Typ II-Diabetes. Perfusion 10: 64

152.

Hanefeld M, Göhler T, Albrecht S, Neumann F, Wildbrett J (1997) Significance of insulin like growth factor 1 for macro- and microangiopathy in non-insulin-dependent diabetes mellitus. Atherosclerosis 134: 157–158

153.

Hofmann R, Albrecht S, Tittel B, Hinkel GK (1997) Monitoring of somatropin using a chemiluminescence immunoassay in cases of children with growth retardation. Eur J Clin Chem Clin Biochem 35: A84

154.

Lauschke H, Zimmermann T, Albrecht S (1997) Lucigenin- and luminol-enhanced chemiluminescence in blood by patients with colorectal cancer. Eur J Clin Chem Clin Biochem 35: A87

155.

May SA, Zimmermann T, Albrecht S (1997) Measurement of phagocytic cell activity of blood cells in patients with oesophageal and gastric carcinoma using chemiluminescence response. Eur J Clin Chem Clin Biochem 35: A88

156.

Nowak R, Albrecht S, Gurth H et al. (1997) Comparison of spontaneous and interleukin 3 induced growth of AML blasts invitro with cytokine secretion of these cells. Blood 90 [Suppl I]: 231b

157.

Albrecht S, Zimmermann T, Scheunert K, Konnegen V, Wunderlich G, Distler W (2002) Chemiluminometric detection of CTx and osteocalcin in cases of postmenopausal women using the Elecsys analyser. Luminescence 17: 196–199

158.

Albrecht S, Zimmermann T, Köppen T, Distler W (2002) Bioluminometric tumorchemosensitivity-assay (TCA) in cases of gynaecology malignancies — useful as pretherapeutical factor? Luminescence 17: 206–208

159.

Bergert H, Ockert D, Zimmermann T, Albrecht S, Kessler U, Saeger HD (2002) Intraoperative chemiluminometric assay during surgery for primary hyperparathyroidism. Luminescence 17: 195–196

160.

Kersting S, Zimmermann T, von Gagern G, Ratayczak D, Albrecht S, Ockert D, Saeger HD (2002) Regulation of the ischemia reperfusion syndrome in liver ischemia by transcription factors — a clinical trial using chemiluminometric methods. Luminescence 17: 193–195

161.

Oehlschläger S, Albrecht S, Hakenberg OW, Manseck A, Froehner M, Zimmermann T, Wirth MP (2002) Measurement of free radicals and NO by chemiluminescence to identify the reperfusion injury in renal transplantation. Luminescence 17: 130–132

162.

Zimmermann T, Albrecht S, Kersting S, Alldinger I, von Gagern G, Saeger HD (2002) Regulation of the inflammatory response in mononuclear blood cells in septic patients. Luminescence 17: 280–282

163.

Zimmermann T, Albrecht S, von Gagern G, Grützmann R, Alldinger I, Kersting S, Saeger HD (2002) The role of IκBα on regulation of inflammatory response in septic patients. Luminescence 17: 289–291

164.

Albrecht S, Zimmermann T, Brandl H (2003) Abstracts Dresden Chemiluminescence Days. Clin Lab 541–570

165.

Albrecht S, Zimmermann T, Brandl H (2004) Lumineszenzapplikationen. PdN-Chem 53: 22–33

166.

Albrecht S, Zimmermann T, Brandl H (2001) Chemiluminescence at the turn of the Millennium. Schweda, Dresden

Titel: Hormondiagnostik mit Chemilumineszenz
verfasst von: PD Dr. S. Albrecht
T. Zimmermann
W. Distler
Publikationsdatum: 01.04.2005
Verlag: Springer-Verlag
Erschienen in: Die Gynäkologie / Ausgabe 4/2005
Print ISSN: 2731-7102
Elektronische ISSN: 2731-7110
DOI: https://doi.org/10.1007/s00129-005-1667-3

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Hormondiagnostik mit Chemilumineszenz

Zusammenfassung

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2005

Störungen der Schilddrüsenfunktion

Ovarprotektion bei zytotoxischer Therapie

Neue Verhaltensempfehlungen für Ärzte bei der Zusammenarbeit mit der pharmazeutischen Industrie?

Behandlung intrakavitärer Myome

Hormonelle Therapie des polyzystischen Ovarsyndroms (PLOS)

Aromataseinhibitoren zur Therapie der Endometriose?

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie